Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/29/2010CN101321539B Novel combination of anticholinergics, glucocorticoid, Beta2-agonist, PDE 4 inhibitors and antileukotrienes for the treatment of inflammatory disease
09/29/2010CN101317845B Pharmaceutical use of 6-aryl substituted pyridine compounds
09/29/2010CN101314591B Novel pyrazoles highly-selective marijuana acceptor-1antagon and/or reversed activation agent
09/29/2010CN101314041B Medicine carrying system of polymer micelle and preparation method thereof
09/29/2010CN101313891B Palmatine injection and preparation method thereof
09/29/2010CN101301293B Acidum folicum effervescent tablet and preparation thereof
09/29/2010CN101297974B Pegylated glycosides of aerial parts of epimedium, and preparation and use thereof
09/29/2010CN101293039B Compound essential oil for refreshing oneself, and eliminating fatigue
09/29/2010CN101284125B Attapulgite water-based kibe formulations
09/29/2010CN101278926B Applications of iron chelator in preparation of medicament for preventing or curing hemorrhagic cerebrovascular disease and chronic hydrocephalus after craniocerebral injury
09/29/2010CN101269058B Spraying agent containing diclofenac acid and uses thereof
09/29/2010CN101260080B 3-(2-methyl-5-nitorimidazole)-1,2-propyl ester compound and its preparation method and use
09/29/2010CN101259222B Medicaments for treating bone fracture bone fracture disease
09/29/2010CN101259177B Medicaments for treating chronic bronchitis and confecting method thereof
09/29/2010CN101254262B Wounds antiphogistic and antalgic plaster
09/29/2010CN101250236B Tuckahoe dextran phosphate esterified derivative as well as preparation and use thereof
09/29/2010CN101244227B Chinese medicine pill mainly for treating nephropathy
09/29/2010CN101244204B Suppository for treating hemorrhoid
09/29/2010CN101244068B Hemsleyadin sustained-release preparation
09/29/2010CN101244060B Leonurus heterophyllus alkaloid composition
09/29/2010CN101234204B High molecule bonding adriamycin medicine, nano capsule and preparation thereof
09/29/2010CN101229335B Enzyme method for preparing smilax scobinicaulis total saponin extract
09/29/2010CN101228137B Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
09/29/2010CN101214344B Chinese medicine preparation for treating coronary disease and stenocardia and preparation thereof
09/29/2010CN101209256B Polydatin medicinal composition containing polyvinyl pyrrolidone
09/29/2010CN101204375B Strontium ranelate dry suspension
09/29/2010CN101181385B Medicament for dispelling scar and preparation method thereof
09/29/2010CN101181369B Compound prescription for curing osteoarthropathy as well as preparation technique thereof
09/29/2010CN101175495B Anti-cancer compound combination
09/29/2010CN101163484B The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
09/29/2010CN101138544B Diclofenac or the salt partial film forming gel composition and uses thereof
09/29/2010CN101129469B Traditional Chinese medicine composition for preventing and controlling cardiovascular disease
09/29/2010CN101129391B Medicament for eliminating OH free radical
09/29/2010CN101129346B Ambroxol hydrochloride oral cavity disintegrating tablet and method of producing the same
09/29/2010CN101125837B C-glycosides type slycolipid compounds and use thereof
09/29/2010CN101120930B Omeprazole composition and preparing process thereof
09/29/2010CN101116665B Malaria-resisting arteannuin naphthoquine compound composition
09/29/2010CN101112405B Drug for curing coronary disease and method for preparing the same
09/29/2010CN101112360B Allicin fatty milk injection and preparation technics thereof
09/29/2010CN101108190B Application of cryptotanshinone in preparation of medicine preventing and controlling autoimmune disease
09/29/2010CN101103964B Sustained-release preparation containing felodipine and preparation method thereof
09/29/2010CN101102761B Use of lignan compounds for treating or preventing inflammatory disease
09/29/2010CN101094666B Improvement of image quality in the eye
09/29/2010CN101085986B SARS coronavirus disturbance RNA and its uses
09/29/2010CN101081203B Hydrogel, alcogel pharmaceutical uses
09/29/2010CN101074227B Phosphine acyloxy quinazoline derivatives and their medicine uses
09/29/2010CN101072771B Cgrp receptor antagonists
09/29/2010CN101068812B Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
09/29/2010CN101061110B Heterlcyclic diamide insecticides
09/29/2010CN101061106B Potentiators of glutamate receptors
09/29/2010CN101049466B Ointment of Chinese herbal medicine for treating burn and scald without pain, and scar, and preparation method
09/29/2010CN101049336B New composition of medication for anti cancer
09/29/2010CN101035762B Alkil-pyridines as 11-beta inhibitors for diabetes
09/29/2010CN101035548B Steroidal saponin pharmaceutical composition, the preparation method and use thereof
09/29/2010CN101032511B Health wine for conditioning blood sugar and the preparing method
09/29/2010CN101032507B Bacteria resisting medicine of erythrocin nanometer-emulsion and the preparing method
09/29/2010CN101031565B Substituted 2h-1,3-benzoxazin-4(3h)-ones
09/29/2010CN101027284B Novel crystalline form of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)-piperazine-1-yl]-methanone hydrochloride
09/29/2010CN101024085B Precursor medicine for target treatment of colon cancer and preparing method
09/29/2010CN101011534B Chinese medicine preparation for treating ulcerative proctitis and its preparation process
09/29/2010CN101011403B Pharmaceutical composition of adefovir dipivoxil and its preparation method
09/29/2010CN101006087B Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
09/29/2010CN101006082B Histamine H3 receptor agents, preparation and therapeutic uses
09/29/2010CN101006076B Modulators of ATP-binding cassette transporters
09/29/2010CN101005830B Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
09/28/2010USRE41783 Pyrrolo[2,3-D]pyrimidine compounds
09/28/2010US7803970 preventing and/or treating dry eye conditions; cancer; hormone-related conditions; oral bioavailability, lack of cross-reactivity with other steroid receptors, and long biological half-lives
09/28/2010US7803954 Mandelic acid derivatives and their use as thrombin inhibitors
09/28/2010US7803951 antidiabetic agents; N-({6-bromo-4-[(trans-4-tert-butylcyclohexyl)({[4-(trifluoromethoxy)phenyl]amino}carbonyl)amino]-3,4-dihydro-2H-chromen-7-yl}carbonyl)- beta -alanine; treating or delaying the onset of type 2 diabetes mellitus; hyperglycemia, insulin resistance, or non-insulin dependent diabetes
09/28/2010US7803945 Tetrahydropyridothiophenes
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
09/28/2010US7803930 Antisense modulation of apolipoprotein B-expression
09/28/2010US7803925 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells
09/28/2010US7803909 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders
09/28/2010US7803844 Composition for preventing and/or treating bone disease, physiologically functional or health food containing thereof, and pharmaceutical containing thereof as active ingredients
09/28/2010US7803843 the ability of people to consume alcohol while reducing hangovers or other effects of intoxication by administering an effective amount of a cysteamine
09/28/2010US7803842 administering stearyl choline chloride for treating senile dementia with Alzheimer's disease
09/28/2010US7803841 EP2 receptor agonists
09/28/2010US7803840 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate
09/28/2010US7803839 Azetidines as MEK inhibitors for the treatment of proliferative diseases
09/28/2010US7803838 Compositions comprising nebivolol
09/28/2010US7803837 4-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
09/28/2010US7803836 (3-{[4-amino-3-(1-cyclopentyl-pyrrolidin-3-ylamino)-benzenesulfonyl]-isobutyl-amino}-1-benzyl-2-hydroxy-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; active against wild-type HIV and show broad-spectrum activity against mutant HIV exhibiting resistances against known protease inhibitors
09/28/2010US7803835 Substituted acetic acid derivatives
09/28/2010US7803834 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof
09/28/2010US7803833 (2R,5R)-2-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-7-methyl-1,7-diazaspiro[4.4]nonan-6-one or a pharmaceutically acceptable salt thereof; for treating diseases and conditions mediated by modulation of voltage-gated sodium channels; eating disorders, depression, epilepsy
09/28/2010US7803831 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer
09/28/2010US7803830 treatment of depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; methyl-[3-(3-methyl-1H-indazol-5-yl)-3-phenyl- propyl]-amine
09/28/2010US7803829 1H-thieno[2,3-c]pyrazoles, showing a high affinity for the ATP pocket of ABL tyrosine kinase; compounds are thus ATP-competitive tyrosine kinase inhibitors displaying a significant inhibitory potency towards BCR-ABL inhibitor-resistant T315I ABL mutants; imatinib-resistant chronic myelogenous leukemia
09/28/2010US7803827 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents; 1-(aminosulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(3,4-dimethylphenyl)-2-imidazolidinone
09/28/2010US7803826 3-[3-(3-chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]propane-1-sulfonic acid amide; anti-androgen activity; treatment of prostate cancer, benign prostatic hypertrophy, male pattern baldness, sexual precociousness, common acne, seborrhea
09/28/2010US7803825 1-{4-[4-(pyrrolidin-1-ylmethyl)-1,3-oxazol-2-yl]benzyl}-1H-benzimidazole, used for the treatment of central nervous system disorders
09/28/2010US7803824 Use of inhibitors of Jun N-terminal kinases to treat glaucoma
09/28/2010US7803823 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases
09/28/2010US7803822 thrombin receptor antagonists such as N-cyclopropyl-1-{4-[(ethylamino)carbonyl]phenyl}-5-propyl-1H-1,2,3-triazole-4-carboxamide, useful for the treatment of thrombosis, restenosis, necrosis, cardiovascular disorders, disseminated intravascular coagulation syndrome, nervous system disorders and tumors
09/28/2010US7803821 N-cyclopropyl-N-[(3,4-dimethoxypyridin-2-yl)methyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide; control of phytopathogenic fungi of plants
09/28/2010US7803820 Schizophrenia; bioavailability, solubility, brain penetrancy; in vivo half life; synthesis; such as 3-[3-({4-methyl-5-[4-(pentafluoro-6-sulfanyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)propyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane
09/28/2010US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents
09/28/2010US7803818 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridine-2-one; antagonistic action against AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor and/or inhibitory action against kainate receptor prophylactic agent for neurodegenerative diseases
1 ... 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 ... 7860